HalioDx

HalioDx is an immuno-oncology diagnostics company that provides top-tier diagnostic products and services to oncologists and drug development organizations to guide cancer treatment and advance precision medicine. The company offers a range of unique immune profiling solutions, including its flagship product, Immunoscore, used to evaluate the immune context of tumors as a key determinant of patient prognosis and response to cancer therapy. HalioDx has developed a unique ecosystem of biopharmaceutical partnerships for identifying clinically relevant biomarker signatures, demonstrating their utility in clinical trials, and the subsequent development and commercialization of IVD and companion diagnostic tests. The company operates CLIA-certified laboratories in the U.S. and France, and also has a manufacturing facility in France for developing, producing, and marketing in vitro diagnostic clinical products.